Relationship between the polymorphism of growth hormone receptor Ex3 and the efficacy of rhGH treatment in children with idiopathic short stature

To assess the influence of growth hormone receptor (GHR) Ex3 genotype on the short-term response to recombinant human growth hormone (rhGH) therapy in children with idiopathic short stature (ISS). Thirty prepubertal children with ISS receiving rhGH treatment [0.116±0.02 IU/(kg/d)] were randomly recr...

Full description

Saved in:
Bibliographic Details
Published inZhongguo dang dai er ke za zhi Vol. 12; no. 9; p. 730
Main Authors Lu, Wen-Li, Wang, Wei, Wang, De-Fen, Xiao, Yuan, Huang, Xiao-Ping, Dong, Zhi-Lan
Format Journal Article
LanguageChinese
Published China 01.09.2010
Subjects
Child
Exons
Female
Genotype
Growth Disorders - drug therapy
Growth Disorders - genetics
Human Growth Hormone - therapeutic use
Humans
Male
Polymorphism, Genetic
Receptors, Somatotropin - genetics
Online AccessGet more information

Cover

More Information
Summary:To assess the influence of growth hormone receptor (GHR) Ex3 genotype on the short-term response to recombinant human growth hormone (rhGH) therapy in children with idiopathic short stature (ISS). Thirty prepubertal children with ISS receiving rhGH treatment [0.116±0.02 IU/(kg/d)] were randomly recruited. The GHR Ex3 locus was genotyped using a PCR multiplex assay. The growth data including growth velocity, height SDS for chronological age (HtSDSCA), height SDS for bone age (HtSDSBA) and predict final height were compared in children with different GHR genotypes 6 months after rhGH treatment. After 6 months of rhGH treatment, the children with ISS carrying d3/d3 alleles showed a significantly higher increment in growth velocity than those carrying fl/fl alleles (6.3±1.6 cm/year vs 3.4±0.5 cm/year; P<0.05). The polymorphism in GHR Ex3 is associated with the responsiveness to rhGH treatment, showing that the growth velocity in ISS children with d3/d3 genotype is significantly higher than those with fl/fl genoty
ISSN:1008-8830